Making progress towards a potential new GDNF trial Date 11 October 2022 Over the last 2 years, Vivifi Biotech has made progress towards a trial that aims to overcome the challenges of the last trial. Now, it’s starting work on the final phase of planning.
Ex-international rugby players have an increased risk of developing Parkinson’s Date 6 October 2022 A study following Scottish international rugby players shows they are more likely to develop neurodegenerative conditions compared to the general public.
Artificial intelligence to help identify Parkinson’s Date 23 September 2022 A project involving Parkinson’s UK, shows promise for using artificial intelligence to identify Parkinson’s in brains donated to our Brain Bank.
Hormone produced during exercise protects brain cells in mice Date 16 September 2022 Results from a US study show that a hormone called irisin has the potential to halt the progression of Parkinson’s in mice.
‘Smelling Parkinson’s’ research could make it quicker and easier to diagnose Parkinson’s Date 7 September 2022 Scientists at the University of Manchester have developed a test which could help diagnose Parkinson’s in 3 minutes using a simple skin swab.
Parkinson’s UK funding research into drug that could slow Parkinson’s progression Date 1 September 2022 The £2.9m phase 2 trial of a drug that could slow the progression of conditions like Parkinson's will be funded by the Parkinson's Virtual Biotech, our international drug discovery and development programme.
Parkinson’s UK and Parkinson’s Foundation partner up to speed up the search for new treatments Date 23 August 2022 Over the next 3 years, the US-based Parkinson’s Foundation will invest a minimum of $3m (over £2.4m) into the Parkinson’s Virtual Biotech, our international drug discovery and development programme.
Disappointing results from trials of vaccines for Parkinson’s, but hope for the future Date 12 August 2022 2 clinical trials aiming to reduce the clumps of troublesome alpha-synuclein to protect brain cells have, so far, failed to show a clear benefit for people with Parkinson’s.
Celebrating neuroscience in spring 2023 Date 4 August 2022 We are partnering with the British Neuroscience Association (BNA) to plan and deliver the BNA International Festival of Neuroscience 2023.
Parkinson’s UK celebrity ambassador David ‘Kid’ Jensen takes part in world-first clinical trial Date 22 July 2022 Broadcasting legend and Parkinson's UK celebrity ambassador David ‘Kid’ Jensen is taking part in a world-first clinical trial. The trial will help researchers understand if an anti-sickness drug could treat hallucinations in people with Parkinson’s or Lewy body dementia.
